Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics
Advanced Science · 2026-02 · 13 (10)
DOI: 10.1002/advs.202515860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 07.01.2026. Verfasst von Wenting Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 31000…. Hauptthemen laut MEDLINE: Precision Medicine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 313 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The ultimate goal of cancer theranostics is to deliver imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems─including targeted and tailored releases with excellent spatial, temporal, and dosage control─should be developed. Supramolecular interactions with dynamic, reversible, and directional features enable the design of biomaterials with ordered architectures, tailored morphologies, multiple types of cargo, and controllable functions. Such supramolecular biomaterials are good candidates for oncology applications, as they optimize therapeutic efficacy while minimizing systemic adverse effects. This review summarizes recent advances in intelligent supramolecular biomaterials, with a specific focus on their spatiotemporal control in cancer theranostics. These biomaterials exploit endogenous and exogenous stimuli to trigger their morphological transformation. In particular, their construction approach and working mechanism, which are crucial in guiding tumor theranostics, are elaborated. Furthermore, the significant challenges in clinical translation and future perspectives for such biomaterials are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, Zhejiang, 310027, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310009, China.
ORCID-Profile: Zhengwei Mao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Hu, W., Ye, B., Yu, G., Huang, F., & Mao, Z. (2026). Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics. Advanced Science, 13(10). https://doi.org/10.1002/advs.202515860
Vancouver
Hu W, Ye B, Yu G, Huang F, Mao Z. Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics. Advanced Science. 2026;13(10). doi:10.1002/advs.202515860
BibTeX
@article{Hu2026,
author = {Hu, Wenting and Ye, Binglin and Yu, Guocan and Huang, Feihe and Mao, Zhengwei},
title = {Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {10},
doi = {10.1002/advs.202515860}
}
EUVIMED